INTERNATIONAL BULLETIN AUGUST 2025 |
|
|
The international projects office of the IIS AragΓ³n has created this monthly newsletter through which it will inform about the calls for projects that are open, the events and the conferences that may be interesting in this regard for the research and management staff.
If you want to contact the international projects office you can do so through this email address: international@iisaragon.es. |
|
|
|
|
|
| MSCA Postdoctoral Fellowships 2025: HORIZON-MSCA-2025-PF-01-01
Fellowships will be awarded to outstanding researchers pursuing international mobility. Applications must be submitted jointly by the researcher and a beneficiary entity from the academic or non-academic sector. Postdoctoral Fellowships can be undertaken in Europe (i.e., in an EU Member State or a Horizon Europe Associated Country) or in a third country not associated with Horizon Europe:
Global Postdoctoral Fellowships: These fellowships are open to European nationals or long-term residents who wish to participate in R&D&I projects with organizations outside the EU Member States and Horizon Europe Associated Countries. These fellowships require an initial period abroad of a minimum of 12 and a maximum of 24 months in a non-associated third country, and a mandatory 12-month return period to a host organization located in an EU Member State or a Horizon Europe Associated Country.
Closing date: 10/09/2025
|
|
|
|
|
|
|
|
|
|
|
|
| MSCA Staff Exchanges 2025: HORIZON-MSCA-2025-SE-01-01
MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from all over the world.
Support is provided for the international, intersectoral and interdisciplinary mobility of staff. R+D which promotes the transfer of knowledge between participating organizations.
Mobility through stays
The organizations that form the association contribute directly to the implementation of a joint project of R+D by sending and/or hosting eligible staff. Such a project should explore activities that can build on previous work, but should also go beyond that, generating or strengthening long-term collaborations. The placements should involve physical mobility of eligible staff members and should always take place between legal entities independent of each other.
Closing date: 08/10/2025
|
|
|
|
|
|
|
|
|
|
|
|
| ERC PROOF OF CONCEPT GRANT 2025
These calls are intended to verify the innovative potential of ideas and results derived from projects already funded by ERC projects that are under development or that have been completed during the year prior to the opening date of this call.
Learn more.
Closing date: 18/09/2025
|
|
|
|
|
|
|
|
|
|
|
|
| ERC Starting Grant 2026
ERC-2026-StG: This call is open to talented researchers at the beginning of their research careers who have produced excellent supervised work, are prepared to work independently, and have the potential to become a research leader.
The official information of the call is available at this link.
Closing date: 14/10/2025
|
|
|
|
|
|
|
|
|
|
|
|
| ERC Sinergy Grant 2026
ERC-2026-SyG: This call is open to a group of two to four Principal Investigators (PIs) to jointly address ambitious research problems that could not be addressed by individual PIs and their teams working alone.
The official information of the call is available in the following link.
Closing date: 05/11/2025
|
|
|
|
|
|
|
|
|
|
|
|
| ERC Consolidator Grants 2025
ERC-2026-CoGThese grants are open to researchers of any nationality with 7-12 years of experience since completing their doctorate.
ERC Consolidator Grants are designed to support outstanding Principal Investigators who are at a stage in their career where they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the innovative character, ambition and feasibility of their research proposal.
More information in this link.
Closing date: 13/01/2026
To support applications for these calls, the agency ERC has recorded the webinar on the basic concepts of the Work Programme (WP) 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cluster 1 Health - Single Stage
Destination - Tackling diseases and reducing disease burden
Destination - Ensuring equal access to innovative, sustainable, and high-quality healthcare
Destination - Developing and using new tools, technologies and digital solutions for a healthy society
Destination - Maintaining an innovative, sustainable, and competitive EU health industry
Closing date: 16/09/2025
|
|
|
|
|
|
|
|
|
|
|
|
| Cluster 1 Health - Two Stage
Destination - Living and working in a health-promoting environment
Destination - Tackling diseases and reducing disease burden
Destination - Maintaining an innovative, sustainable, and competitive EU health industry
Destination - Staying healthy in a rapidly changing society
Closing date for the first phase: 16/09/2025 Closing date for the second phase: 16/04/2026
|
|
|
|
|
|
|
|
|
|
|
|
| CANCER MISSION WP2025
Closing date: 16/09/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
| EIC Transition Open 2025
HORIZON-EIC-2025-TRANSITIONOPEN: EIC Transition funds innovation activities that go beyond the experimental proof of concept in the laboratory. It supports both the maturation and validation of your novel technology, from the laboratory to relevant application environments (through the use of prototypes, formulations, models, user trials, or other validation tests), as well as the exploration and development of a sustainable business model and business case for commercialization.
Deadline: 17 / 09 / 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| COSTAction
COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks. Its actions help connect research initiatives across Europe and beyond, and allow researchers and innovators to develop their ideas in any field of science and technology by sharing them with their peers.
Participants planning to submit a proposal for a COST Action should refer to the SESA guidelines and the Open Call Announcement, available on the COST Action page. Documents and Guidelines.
Closing date: 21/10/2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IHI call 11:
The main objectives of the European partnership, the Innovative Health Initiative (IHI), are to translate health research and innovation into tangible benefits for patients and society, and to ensure that Europe remains at the forefront of interdisciplinary, sustainable, and patient-centered health research.
The 11th round of this partnership is being developed in two stages, with topics covering brain dysfunction, the relationship between infections and noncommunicable diseases, pharmacovigilance, type 1 diabetes, and outpatient surgical centers.
More Information.
Closing date for the first phase: 09/10/2025 Closing date for the second phase: 29/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
| EP PerMed. βEducation Call: Guide to Personalized Medicine for Healthcare Professionalsβ
The objective of this call is to provide funding to support the provision and development of educational content for healthcare professionals in the implementation of personalized medicine.
Learn more.
Closing date: 09/09/2025 |
| EP PerMed: Networking Support Call (NSC) 2025: Networking opportunity for preciously funded projects in personalized medicine
The objective of this call is to create networks in the field of personalized medicine, with the aim of promoting the translation and application of research results into clinical practice. More Information.
Closing date: 29/09/2025 |
| EP PerMed: Research Innovation an Technology Call for Proposals (RITC) 2026
Test and Demonstration of Multimodal Data Approaches for Personalized Medicine (MultiPMData2026)
This call seeks to bring together companies and clinical stakeholders (healthcare providers, patients, and researchers) to test innovative solutions in controlled, real-world settings, with the goal of improving the management of multimorbidity.
EP PerMed will fund projects focused on the use of multimodal data to provide more efficient and personalized management for patients with at least two chronic diseases. Projects must test and develop mature solutions in real-world settings, adopt a systemic approach, and integrate six key elements (knowledge, technology, infrastructure, business models, policies, organization, and values). Proposals must include a clear strategy for multimodal health data management.
Consortia must have a clinical partner and at least one SME or industrial partner. Clinical studies can be funded, but not large clinical trials.
Call for applications publication date: early October 2025
Closing date for the first phase: 12/01/2026
Closing date for the second phase: 27/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
On March 31, 2025, the new Digital Europe Work Programme for the period 2025-2027 was published. It focuses on initiatives aimed at boosting the implementation of cutting-edge technologies and promoting technological development, such as the deployment of Artificial Intelligence (AI) and its adoption by businesses and public administrations, cloud and data, cyber resilience, and digital skills.
Health-related topics:
2.2.1.6. Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space
2.2.2.4. Digital solutions for regulatory compliance through data
2.3.1.1. Testing genAI4EU application at scale and under real-world conditions
2.3.3.1. Deployment of cutting-edge multi-modal AI-based solutions in medical Imaging
2.3.3.2. Virtual Human Twins and Artificial Intelligence in health
2.3.3.3. Apply AI: Piloting AI-based image screening in medical centers
5.1.5. Bank Account Registers' Interconnection System (BARIS)
5.1.6. Building capacity to deploy the EEHRxF and digital health services and systems to support the rights of citizens and reuse of health data under EHDS
5.1.7. European Cybersecurity Support Center for hospitals and healthcare Providers
you can check it here |
|
|
|
| The Global Grants for Gut Health
Global Grants for Gut Health is a competitive funding initiative that supports innovative, investigator-led research focused on the human gut microbiota. This program, jointly supported by Yakult and Nature Portfolio, aims to advance scientific knowledge about the fundamental role the gut microbiome plays in human health.
Proposals for research projects are invited. one year duration, which may include both laboratory research and clinical studies, and which explore the role of Nutrition in the modulation of the human gut microbiome and intestinal barrier functionStudies that analyze the interaction between diet, microbial composition, and intestinal barrier homeostasis will be especially encouraged. The detailed scope can be found on the website. For Applicants.
Selected projects must demonstrate scientific rigor, originality or with a significant potential to contribute to the advancement of the field of microbiome research.
Closing date: 09/09/2025 |
|
|
|
|
|
|
|
|
|
|
|
Alzheimer's Drug Discovery Foundation |
|
|
| Drug Development RFP
the summons Drug Development RFP supports studies necessary for the obtaining authorization for early-phase clinical trials (qualifying studies for the application of a Investigational New Drug β IND, or its international equivalent), as well as early-phase clinical trials to evaluate promising pharmacological interventions and devices for Alzheimer's disease (AD) and other related dementias.
This funding opportunity focuses on diverse pharmacological mechanisms and modes of action related to biology of aging and other emerging therapeutic areas in the field of dementia.
More Information here
Cover letter closing date: 15/09/2025 Full proposal closing date: 17/11/2025 |
|
|
|
|
|
|
|
|
|
|
|
| Expanding Theories 2025/2
Financing of up to Β£75.000 per year is available for a maximum of 2 years.
This call supports pilot studies that explore and develop novel concepts that could eventually lead to significant improvements in clinical outcomes, including quality of life, for people with brain tumors.
Proposals that explore innovative approaches that could fundamentally transform our understanding, diagnosis, and/or management of brain tumors will also be considered.
The objective of this call is to generate sufficient data to support future applications for larger-scale projects to national or international funding agencies. This call does not fund clinical trials.
More Information here
Deadline: 24 / 09 / 2025 |
|
|
|
|
|
|
|
|
|
|
|
| Alzheimer's Disease Research Request for Proposals
Alzheimer's Disease Research, a program of the Bright Focus Foundation, provides research funding to scientists both in the United States and abroad who are conducting pioneering research aimed at better understanding, preventing, and treating Alzheimer's disease.
They are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges, and strongly encourage applications from individuals from groups underrepresented in Alzheimer's disease research.
More Information here
Deadline: 29 / 09 / 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
02/09/2025 EP PerMed Webinar: Education Call 2025
Questions and Answer session with EIT Health on submitting applications for the EP PerMed Education Call 2025.
Register here.
28/10/2025 EACR-OECI: Patient Involvement in Cancer Research
The patient perspective in cancer research is vital to creating more effective, compassionate, and equitable research that truly benefits those affected by the disease. Patient focus organizations are working on empowering patients to actively participate in decision-making, treatment planning, and research design, fostering better outcomes and relevance, but there is still work to be done.
By actively incorporating patients' perspectives, research can better address key aspects of cancer care, such as patients' quality of life, symptom management, and treatment side effects. Patients can also highlight gaps in communication and in current treatment options or areas where existing therapies fall short, leading to the development of innovative approaches to care.
This virtual event, a collaboration between theEACR and the OECI (Organisation of European Cancer Institutes), will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research.
More Information
28/10/2025 PerMed RITC2026
The European Association for Personalized Medicine (EP Per Med), within the framework of Horizon Europe, will hold an information day to present the first Research, Innovation and Technology Call (RITC2026) to the research community in an online format.
The session will detail the objectives of the call, the planned timeline, and the conditions for participation. This initiative is part of the implementation of the Strategic Research and Innovation Agenda (SRIA) for Personalized Medicine (2023).
Registration will open soon. More information soon.
|
|
|
|
|
|
|
|
|
|
|
|
|
